CD34 and acute myeloid leukemia: First, we used a DNA methylation microarray for 450 k CpG sites to profile genome‐wide DNA methylation in AML blasts of patients with or without t(8;21) (Appendix Table S1) and normal bone marrow (NBM) CD34+ cells.